Journalists working on stories related to high-risk pregnancies or the Society for Maternal-Fetal Medicine can contact Greg Phillips, Director of Communications, at press@smfm.org for referrals to MFM experts and to request additional information. The press office is open Monday through Friday from 9:00 AM to 5:00 PM ET.
If NICHD funding for the MFMU Network were reduced or eliminated, we would lose the ability to ask and answer these research questions at the scale pregnancy care requires. Continue Reading
SMFM launches its first annual High-Risk Pregnancy Awareness Week, June 1-8, a campaign to raise awareness among expectant parents and families, policymakers, researchers, and the public about high-risk pregnancies and the critical role that MFM subspecialists play in managing complex pregnancies. Continue Reading
HDPs, including preeclampsia, superimposed preeclampsia, chronic hypertension, gestational hypertension, Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) syndrome, and eclampsia, are the leading cause of maternal and infant illness and death in the United States. Continue Reading
The Society for Maternal-Fetal Medicine is pleased to announce this year’s awards presented at the SMFM 2026 Pregnancy Meeting™ in Las Vegas, NV. Continue Reading
Prescribing daily aspirin at the first prenatal visit to all pregnant patients was associated with an overall reduction in the development of severe preeclampsia, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading
In just a few weeks, SMFM will welcome experts, researchers, students, and healthcare professionals in obstetrics Marvin Williams, DOPoster Chair to the 2026 Pregnancy Meeting in Las Vegas, Nevada. I am proud to share that we have an impressive research lineup! As Dr. Allison Bryant shared... Continue Reading
Prepregnancy counseling, assembling multidisciplinary care teams, and referring to centers with expertise are critical in managing pregnant patients with heart failure to optimize maternal and newborn health outcomes, according to new guidance issued by SMFM. Continue Reading
By: Adam K. Lewkowitz, MD, MPHS, and Emily S. Miller, MD, MPH On July 21, 2025, the Food and Drug Administration (FDA) convened a roundtable panelist discussion on the use of selective serotonin reuptake inhibitors (SSRIs), a class of antidepressant medication, in pregnancy. The FDA... Continue Reading
By Kristen A. Cagino, MD As physicians, we recognize that medical practice is built on a foundation of research. Discovering new therapies, navigating a global pandemic, and identifying the safest, evidence-based management strategy for complex conditions all rely on rigorous, well-designed... Continue Reading
When I was a medical student, the disease process of preeclampsia was one of the things that sparked my interest in the field of obstetrics. Today, I am passionate about teaching patients and their families about preeclampsia because it is one of the most common conditions I manage. What Is... Continue Reading
Media Contact:Karen Addis, APRkaren@addispr.com+1 (301) 787-2394 New National Study Finds Homicide and Suicide is the #1 Cause of Maternal Death in the U.S. Denver, Colo. ― In the medical community, research has traditionally focused on how to prevent and treat the leading medical causes of... Continue Reading
Washington, DC—The Society for Maternal-Fetal Medicine (SMFM) has received a multiyear award totaling more than $1.3 million from the Centers for Disease Control and Prevention (CDC) to build capacity and collaboration among maternal health professional organizations and to improve care... Continue Reading
